Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS Digitally Transforms QIAGEN's Global Research Platform to Improve User Experience with New Digital Capabilities

Posted On: 2020-02-25 12:02:55


Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization, has transformed QIAGEN's GeneGlobe, a genomics-based research platform for biology and biomedical researchers, to improve customer experience.

QIAGEN is a leading provider of sample to insight solutions for customers in life sciences and molecular diagnostics. To cater to the expectations of a large proportion of researchers who are digital natives, it was looking to transform its GeneGlobe research platform. The company partnered with TCS given its deep contextual knowledge, strong digital capabilities in cloud and microservices, as well as expertise in designing intuitive, customer-centric platforms.

TCS adopted a cloud-based microservices architecture and revamped the GeneGlobe platform by leveraging industry-best DevOps practices and design thinking approaches. The new platform, GeneGlobe - Design & Analysis Hub, offers an intuitive interface, helping researchers to find the right product in just three steps.

Powerful algorithms link products to biological targets, so researchers can explore and expedite decisions on products within the relevant context. Personalized dashboards and product builders are now easier to use and enable the creation of virtually any custom product for a specific research question. This transformation has helped QIAGEN to boost overall digital revenue.

"We are excited that the new GeneGlobe Design & Analysis Hub is now available and ready to provide customers with next-level experiment planning, execution and follow-up. With GeneGlobe we are offering researchers one place to navigate knowledge, tools and analyses for their specific target, saving researchers time and budget," said Peter Rene Hesse, Head of Digitalization, QIAGEN Life Sciences Business. "The partnership with TCS helps us to drive growth and transformation aligned with our company vision of making improvements in life possible."

"Our long-term strategic partnership with TCS has allowed us to tap into their deep contextual knowledge of the life sciences industry. This has continuously paid dividends both to the overall success of our business and, more importantly, to the experience we're able to provide to our customers," said Dr Thomas Schweins, Senior Vice President and Head, Life Sciences Business, QIAGEN.

"With the new intuitive, customer-centric design and scalable cloud-native architecture, QIAGEN's platform delivers a superior user experience that will attract a new class of researchers, and accelerate and spur new research that improves lives," said Vikas Jain, Business Head, Life Sciences, TCS. "Our ability to harness the power of digital technologies to reimagine business models and enhance customer experiences has made us the preferred transformation partner to our life sciences customers in their Business 4.0™ journeys."

TCS partners with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0 framework. TCS offers a full set of digital transformation services and solutions including advisory services, predictive and prescriptive analytics, genomics research, advanced platform solutions, digital content factory, digital marketing and cognitive business operations.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2116.3 as compared to the previous close of Rs. 2156.3. The total number of shares traded during the day was 80671 in over 6311 trades.

The stock hit an intraday high of Rs. 2178.95 and intraday low of 2106.65. The net turnover during the day was Rs. 173264286.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

ONGC terminates contract with Dolphin Offshore Enterprises India Ltd

Bharat Dynamics Ltd records turnover of Rs. 3095 crore in FY2019-20

Seamec Ltd bags contract from ONGC for vessel Seamec II

Kotak Leadership Takes 15% Cut in Salary

SpiceJet operates its first cargo freighter to Singapore to bring critical medical equipment to India

Axis Bank-backed TReDS platform, Invoicemart crosses USD 1 billion throughput

UniOne Foundation Donates to PM Cares Fund

Godawari Power & Ispat Ltd resumes partial operations

Zydus receives tentative approval from the USFDA for Empagliflozin Tablets

Ind-Ra withdraws rating of Sterling and Wilson Solar Ltd

CRISIL updates on credit ratings to IDFC First Bank

Flipkart, ICICI Lombard and Go Digit General Insurance come together to offer COVID-19 focused health insurance

SMS Pharmaceuticals Limited updates on Ranitidine issue

Chalet Hotels Limited updates on credit rating

Dr. Reddy's Laboratories Ltd receives EIR from USFDA for API plant 5

Polyplex Corporation Ltd board approves buy back up to Rs. 475

Godrej Consumer Products Ltd - Quarterly Update: 4QFY20

OnMobile Global Ltd board approves buy back of up to Rs. 54.10 crore

CSB Bank Limited updates on ratings

SMS Lifesciences India Limited update on Ranitidine HCL

IndiGrid looks to acquire US$ 140 Mn (INR 10.8 Bn) transmission project and also intends to add Solar energy in the portfolio

Gulf Oil Lubricants India Ltd board approves interim dividend of Rs. 7

Bank of Baroda revises Marginal Cost of Funds Based Lending Rate w.e.f April 12, 2020

Novelis Receives Last Clearance for Aleris Acqusition

Coronavirus: DRDO, ITI to team up to manufacture portable ventilators

Tata Power bestowed upon with the highest accolade in the field of Innovation, 'The Edison Award'

L&T to raise Rs. 9000 crore

Lincoln Pharmaceuticals Ltd update on impact of Novel Coronavirus (COVID-19)

Swaraj offers facility of a standby tractor to help farmers amid Coronavirus

NIIT Ltd. launches a free 'Remote Work Excellence Kit' to support the fight against COVID-19

Aurobindo Pharma receives USFDA Approval for Fluoxetine Tablets

ITC provides Meals, Food Products & Hygiene Essentials to the Needy across 17 States

Zydus receives final approval from USFDA for Imatinib Mesylate Tablets

CRISIL reaffirms ratings of Mahindra and Mahindra Ltd

IndiGo enters Brand Finance Top 50 Airlines list recognising the most valuable and strongest airline brands in 2020

CRISIL rating on Rs. 20 crore Non-Convertible Debentures of BASF India Ltd

Granules India Limited announces approval of Butalbital, Acetaminophen and Caffeine Capsules USP

Hero MotoCorp launches the innovative 'Hero Colabs - The Design Challenge' to promote collaboration & co-creation

Titan Company Ltd - Quarterly Update: Q4 FY'20

L&T Construction bags contracts for its Power Transmission & Distribution Business

IDBI Bank Ltd board approves proposal to sell stake in insurance company

Welspun Corp Limited provides business update of Saudi Arabia plant

Kolte-Patil Developers undertakes strategic land monetization of a portion of Sector R10 of Life Republic for INR 91 crore

Marico Ltd - Quarterly Update: Q4 FY20

Cipla receives final approval for generic version of Proventil® HFA Inhalation Aerosol

Punjab & Sind Bank board to consider fund raising through equity issue

Vedanta Sesa Goa Iron Ore contributes Rs. 1 crore to Goa state COVID-19 Relief Fund

IDBI Bank Ltd board approves borrowing for FY 2020-21

Seniority and RPG Life Sciences Launch SafeSeniors - India's First COVID-19 Risk Monitoring Tool for Senior Citizens

Paisalo Digital Ltd to consider various options for raising funds







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019